Chemotherapy for ovarian cancer in Israel — get 3 top clinic matches with costs

Israel provides advanced ovarian cancer chemotherapy through Hyperthermic Intraperitoneal Chemotherapy (HIPEC), targeted PARP inhibitors, and immunotherapy. Leading centers like Assuta and Sourasky (Ichilov) utilize genetic profiling to tailor dose-dense regimens and antibody-drug conjugates, achieving high survival rates for complex cases within JCI-accredited facilities.

• HIPEC treatment: Heated drugs circulate in the abdomen during surgery to kill microscopic cells.
• Targeted therapy: Maintenance protocols involve PARP inhibitors and folate receptor-alpha agents like Elahere.
• Immunotherapy access: Advanced medications like Keytruda boost immune responses against specific cancer markers.
• Neoadjuvant protocols: Specialized infusions shrink tumors before debulking surgery to improve surgical outcomes.

Bookimed Expert Insight: Israeli oncology centers demonstrate high expertise by integrating clinical trials directly into treatment plans. Dr. Irina Stepfansky at Sourasky serves as a primary investigator for Phase I-III trials. This gives patients access to emerging protocols like RNA-based nanodrugs often unavailable in standard hospitals.

Patient Consensus: Patients often emphasize the necessity of BRCA and HRD genetic testing to unlock maintenance therapies. Many recommend using cooling mitts during infusions to manage side effects and maintain quality of life.

Targeted therapies for ovarian cancer in Israel prioritize personalized protocols based on molecular profiling. Key treatments include PARP inhibitors for BRCA mutations, angiogenesis inhibitors like Bevacizumab, and advanced antibody-drug conjugates such as Mirvetuximab soravtansine for folate receptor alpha-positive cases within JCI-accredited centers in Tel Aviv.

• PARP inhibitors: Use Olaparib and Niraparib for maintenance in HRD-positive tumors.
• Antibody-drug conjugates: Mirvetuximab soravtansine (Elahere) targets platinum-resistant, folate receptor alpha-positive cases.
• Combination protocols: Doctors pair Pembrolizumab (Keytruda) with specialized niraparib cycles for improved outcomes.
• Molecular profiling: Specialists use FoundationOne CDx to identify specific KRAS or HER2 mutations.

Bookimed Expert Insight: Israel offers exceptionally fast access to phase I-III clinical trials for B7-H4 targeted drugs. Dr. Irina Stepfansky at Sourasky Medical Center (Ichilov) coordinates these trials. This allows patients to access therapies like Avutometinib years before they reach standard global markets.

Patient Consensus: Patients emphasize that biomarker testing for FRα and HRD status is essential before starting. Many highlight the availability of compassionate use programs for new drugs not yet on national lists.

Israel provides specialized molecular diagnostics for ovarian cancer, using genetic profiling to identify BRCA1/2 mutations and FRα expression. JCI-accredited centers like Assuta and Sourasky perform comprehensive tumor sequencing. These diagnostics guide personalized protocols including targeted therapy, immunotherapy, and enrollment in advanced clinical trials.

• Molecular markers: Testing identifies BRCA1/2 and Folate Receptor Alpha (FRα) status.
• Leading facilities: Assuta Medical Center performs 685,000 diagnostic procedures annually near Tel Aviv.
• Expert oversight: Specialists like Dr. Irina Stepfansky manage advanced phase I-III clinical trials.
• Diagnostic timeline: Complex genomic profiling requires more than a 1–2 day laboratory turnaround.

Bookimed Expert Insight: While research into liquid biopsies and cell-free DNA screening is high in Israel, these tools are often part of clinical trials rather than standard care. Clinics like Assuta pair JCI-accredited diagnostic accuracy with high surgical volume, performing 92,000 operations annually, which ensures biological samples are handled by high-capacity, experienced pathology teams.

Patient Consensus: Patients emphasize verifying Folate Receptor Alpha status before beginning treatment, as this specific diagnostic result determines eligibility for many modern targeted therapies. They also note that molecular testing is time-intensive, so international travelers should plan for a longer diagnostic window.

Immunotherapy is an active treatment option for ovarian cancer in Israel, primarily used for advanced or recurrent cases. Israeli oncologists utilize FDA-approved drugs like Pembrolizumab and Dostarlimab for patients with specific genetic markers, often integrating them into personalized protocols based on molecular testing.

• Approved therapies: Clinics prescribe Pembrolizumab (Keytruda) for microsatellite instability-high or mismatch repair deficient tumors.
• Specialized expertise: Experts like Dr. Irina Stepfansky manage advanced protocols for gynecologic oncology cases.
• Clinical trials: Patients access innovative treatments including tumor-infiltrating lymphocyte therapy and RNA-based nanodrugs.
• Advanced diagnostics: Molecular tests like FoundationOne CDx identify unique tumor profiles to determine eligibility.

Bookimed Expert Insight: Israeli oncology centers like Assuta and Sourasky prioritize targeted therapies over pure immunotherapy for initial treatment. Data shows that doctors often recommend testing for Homologous Recombination Deficiency before immunotherapy. This approach identifies patients who benefit more from PARP inhibitors, ensuring more effective first-line outcomes.

Patient Consensus: Patients emphasize that immunotherapy is rarely a standalone or first-line choice for this diagnosis. Success often depends on participating in clinical trials for platinum-resistant cases where standard chemotherapy has failed.

The standard first-line chemotherapy for ovarian cancer is a combination of carboplatin and paclitaxel. This doublet regimen typically involves 6 cycles administered intravenously every 3 weeks. Surgeons often provide this adjuvant treatment after debulking to eliminate residual cancer cells.

• Core regimen: Carboplatin and paclitaxel (Taxol) form the primary platinum-taxane doublet therapy.
• Treatment duration: Most protocols require 6 cycles over 5 months for maximum efficacy.
• Delivery methods: Options include standard intravenous infusion or localized intraperitoneal therapy for advanced stages.
• Maintenance therapy: Doctors may add PARP inhibitors like Lynparza or Bevacizumab to prevent recurrence.

Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center utilize advanced sequencing. Dr. Irina Stepfansky emphasizes neoadjuvant chemotherapy, where 3 cycles precede surgery. This specific timing often shrinks widespread tumors, making surgical debulking more successful and improving overall survival rates.

Patient Consensus: Completing all six cycles is vital as clinical data confirms its effectiveness for long-term remission. Patients often suggest asking about BRCA mutation testing to qualify for targeted maintenance therapies like PARP inhibitors.

Treatment goals for recurrent ovarian cancer focus on extending survival, suppressing disease progression, and maximizing quality of life. Since the condition is managed as a chronic illness, specialists aim to achieve further remissions and provide extended time off treatment while managing symptoms effectively.

• Disease stabilization: Using systemic chemotherapy to control growth and achieve no evidence of disease.
• Survival extension: Employing targeted therapies or PARP inhibitors to prolong overall lifespan significantly.
• Symptom management: Prioritizing palliative care to ensure daily comfort and high functional levels.
• Maintenance strategy: Utilizing angiogenesis inhibitors to delay future flare-ups and maintain responsiveness.

Bookimed Expert Insight: Israeli oncology centers like Assuta or Sourasky often emphasize specialized diagnostic precision, such as RUTH mammography or advanced PET-CT. This allows experts like Dr. Irina Stepfansky to tailor clinical trials specifically for platinum-resistant cases. Selecting a JCI-accredited facility ensures these advanced protocols meet international safety standards.

Patient Consensus: Many patients find that treating recurrence like a manageable chronic condition reduces emotional stress. They highlight the importance of proactive CA-125 monitoring to catch changes early before symptoms appear.

Chemotherapy for ovarian cancer typically causes temporary fatigue, hair loss, and peripheral neuropathy. While attacking malignant cells, platinum-based agents and taxanes affect healthy tissues. Israeli oncologists mitigate these impacts through personalized dosing and supportive medications to maintain patient quality of life during cycles.

• Physical exhaustion: Severe fatigue can leave patients bedridden for 3 to 5 days post-session.
• Neurological changes: Taxanes may cause numbness, tingling, or buzzing in fingers and toes.
• Gastrointestinal distress: Treatment often causes severe constipation, nausea, and bitter taste perceptions.
• Immunological risk: Low white blood cell counts significantly increase the risk of systemic infections.

Bookimed Expert Insight: While many focus on hair loss, our data shows patients often overlook sensory side effects. For instance, cisplatin-based regimens commonly used in JCI-accredited centers like Assuta carry higher risks for tinnitus. Modern Israeli protocols now incorporate scalp cooling and specialized hydration to reduce specific side effects like chemical sweat odors or localized skin peeling.

Patient Consensus: Patients frequently report that hair loss occurs rapidly, often within 6 days of the first dose. Many recommend keeping a daily symptom journal to track bowel habits and neurological changes for better oncologist consultations.

Israel is a premier neurosurgery hub due to its fusion of high-density medical innovation and elite surgical expertise. Top facilities like Sheba Medical Center integrate AI-guided navigation and real-time intraoperative MRI. Specialized centers report 98% success rates for complex procedures including awake craniotomy and movement disorder treatments.

• Advanced technology: Clinics utilize MRI-guided focused ultrasound (MRgFUS) and robotic systems for incisions.
• Surgical expertise: Surgeons like Dr. Zvi Ram lead international associations with 25+ years experience.
• Rapid access: International patients typically schedule complex brain or spine surgeries within 2–4 weeks.
• Accredited care: Major centers like Sourasky (Ichilov) and Assuta hold JCI accreditation for safety.

Bookimed Expert Insight: Data shows a clear divide between public and private options in Israel. Private centers like Assuta Medical Center perform over 92,000 operations annually and allow patients to select their specific lead surgeon. This is a vital advantage for complex cases where a specific expert like Dr. Eli Ashkenazi is preferred for his 1,000+ spine surgery record.

Patient Consensus: Patients emphasize bringing original imaging on a USB for local review to streamline the surgical plan. They also note that private packages often include hotel coordination and airport transfers, making the logistics much smoother.

Israeli neurosurgeons treat a full spectrum of conditions ranging from brain and spinal tumors to complex functional disorders. Specialized centers utilize advanced technologies like Gamma Knife, deep brain stimulation, and intraoperative MRI to manage epilepsy, Parkinson disease, and cerebrovascular pathologies with high precision.

• Oncological conditions: Treatment for gliomas, meningiomas, and pituitary tumors using skull base resection.
• Functional disorders: Management of Parkinson disease and essential tremors via deep brain stimulation.
• Spinal pathologies: Correction of scoliosis, herniated discs, and spinal tumors using robotic systems.
• Cerebrovascular care: Surgical repair of brain aneurysms and arteriovenous malformations with endovascular interventions.
• Pediatric neurosurgery: Specialized care for hydrocephalus and congenital anomalies at dedicated children centers.

Bookimed Expert Insight: Israeli hospitals often combine specialties to handle complex cases. At Sourasky Medical Center, neurosurgeons like Dr. Zvi Lidar bridge neurosurgery and orthopedics for spinal care. This multidisciplinary approach allows clinics to perform 34,000+ operations annually. Choosing a facility with this crossover expertise often leads to more comprehensive treatment plans for degenerative diseases.

Patient Consensus: Patients value the ability to access specialized treatments like fluorescence-guided surgery for tumors which are often unavailable elsewhere. Many note that the staff is fluent in English and provides clear communication through teleconsultations before traveling.

Israel is home to world-renowned neurosurgery centers like Sourasky Medical Center, Sheba Medical Center, and Hadassah Medical Center. These facilities are globally ranked for treating complex brain tumors, spinal disorders, and movement diseases. They utilize advanced technologies like Gamma Knife, robotic systems, and intra-operative MRI.

• Sourasky (Ichilov): Performs 2,500+ neurosurgical operations yearly with a 98% success rate in Tel Aviv.
• Sheba Medical Center: Ranked among the world's top 10 hospitals. It treats 1.9 million patients annually.
• Hadassah Medical Center: A Nobel Peace Prize nominee. It leads in pediatric neurosurgery and gene-based therapies.
• Assuta Medical Center: Israel's largest private facility. It specializes in minimally invasive spine and brain surgeries.
• Schneider Children's: The primary center for pediatric neurosurgery. It treats 275,000 children every year.

Bookimed Expert Insight: Our data shows that while most patients focus on Tel Aviv, Rambam Medical Center in Haifa offers unique expertise in neuro-trauma. It operates a specialized neuro-ICU and serves nearly 1 million patients annually. This makes it an essential choice for complex post-trauma brain surgeries that requires intensive recovery support.

Patient Consensus: Patients note it is important to start consultations early. They often highlight that the precision and follow-up care for complex brain tumors exceeded their expectations. One patient emphasized how quickly they could connect with top professors for second opinions during critical neurosurgical cases.

Israel's leading neurosurgeons include Prof. Zvi Ram, Prof. Shlomi Constantini, and Prof. Itzhak Fried at Sourasky Medical Center. These specialists hold leadership roles in the European Association of Neurosurgical Societies (EANS) and the World Society for Stereotactic and Functional Neurosurgery (WSSFN). They utilize advanced intraoperative mapping and robotic systems.

• Prof. Zvi Ram: Expert in minimally invasive brain tumor surgery and gene-based oncology therapies.
• Prof. Shlomi Constantini: Specializes in complex pediatric neuro-endoscopy and brain tumor microsurgery.
• Prof. Itzhak Fried: Authority on epilepsy surgery, functional brain mapping, and deep brain stimulation.
• Dr. Eli Ashkenazi: Leading spine surgeon at Assuta, specializing in the innovative TOPS system.

Bookimed Expert Insight: Data from Sourasky and Sheba indicates a strong correlation between high surgical volumes and patient safety. For example, Sourasky performs 34,000+ operations annually with a 90% oncology success rate. Patients seeking complex tumor removals should prioritize centers like these where surgeons perform hundreds of specific cases each year.

Patient Consensus: Patients emphasize the importance of finding a surgeon who specializes specifically in your condition rather than a generalist. Many note that high-volume centers provide better access to English-speaking staff and coordinated care for international visitors.

International neurosurgery patients in Israel must provide comprehensive medical records including recent MRI or CT scans translated into English. Admission requires a clinical review by specialists to confirm treatment feasibility. Hospitals often mandate full advance payment or a significant deposit before confirming surgery dates or issuing visa support letters.

• Medical documentation: Submit detailed English-translated reports and imaging for clinical review within 48 hours.
• Financial clearance: Provide proof of funds for approximately $9,000 to $16,000 for treatment.
• Visa support: Clinics like Sourasky Medical Center (Ichilov) issue official letters for medical B-2 visas.
• Consultation phase: Initial assessment often occurs via online consultation with surgeons like Dr. Strauss Ido.

Bookimed Expert Insight: Data shows that top Israeli facilities like Sheba Medical Center and Hadassah Medical Center handle massive patient volumes, exceeding 1,000,000 people annually. This high demand means clinics prioritize complex or rare cases over routine procedures. Patients with unique or high-risk conditions often receive faster admission approval than those seeking standard treatments available elsewhere.

Patient Consensus: Patients note that having all imaging results ready in English is essential for quick scheduling. Many emphasize that while the medical care is excellent, coordinating around Shabbat closures is necessary to avoid unexpected diagnostic delays.

A standard stay for neurosurgery in Israel ranges from 10 to 14 days for uncomplicated cases. Patients undergoing complex procedures like brain tumor removal or deep brain stimulation often require 4 to 6 weeks. This timeline covers pre-operative diagnostics, the surgical procedure, and essential post-operative monitoring.

• Hospitalization duration: Minimally invasive procedures require 1–3 days. Regular craniotomies average 3–10 days.
• Local recovery: Stay in Israel for 7–14 days post-discharge for mandatory follow-up checks.
• Flight safety: Surgeons recommend waiting 4–6 weeks before flying to stabilize internal head pressure.
• Follow-up schedule: In-person clinical reviews typically occur at days 3, 7, and 14 post-surgery.

Bookimed Expert Insight: Data from Sourasky Medical Center shows they treat over 400,000 patients annually with high success rates. Clinics with such high volumes, like Hadassah or Assuta, often have streamlined discharge protocols. This helps international patients transition to hotel-based recovery faster while maintaining access to top specialists.

Patient Consensus: Patients note it is vital not to rush home too early. Some travelers extended their stay to 3 weeks due to swelling or to ensure they received final surgeon clearance before flying.

Israeli neurosurgery uses robotic guidance, real-time 3D imaging, and incisionless technologies to minimize physical trauma. Systems like Mazor Robotics provide sub-millimeter precision for spine implants. MRI-guided focused ultrasound (MRgFUS) treats tremors without incisions. These advanced tools ensure high accuracy and reduce recovery times.

• Robotic systems: Mazor and ROSA robotics enable precise instrument placement through tiny incisions.
• Incisionless ultrasound: MRgFUS uses high-intensity sound waves to treat brain tissue without anesthesia.
• Digital navigation: Intraoperative MRI and 3D mapping allow surgeons to verify results in real-time.
• Advanced endoscopy: Transnasal and trans-orbital approaches remove tumors without traditional skull-opening craniotomies.

Bookimed Expert Insight: Israeli clinics like Sourasky or Hadassah integrate proprietary Israeli-born technologies like Surgical Theater before they hit global markets. Our data shows these centers often use VR flight-through models for pre-surgical planning. This allows surgeons to rehearse complex cases, which is a key factor in their 90% success rates.

Patient Consensus: Patients note that technologies like the Gamma Knife allowed them to return home in days rather than weeks. Many move from traditional 10cm incisions to cuts under 2cm when using robotic-assisted systems.

Israel is a global leader in neurosurgery due to its integration of proprietary medical innovations and internationally trained specialists. High-capacity centers like Sourasky Medical Center (Ichilov) perform over 34,000 annual surgeries. Patients access advanced techniques like awake craniotomy and MR-guided focused ultrasound.

• Advanced technology: Facilities use CyberKnife, Gamma Knife, and robotic systems for precision.
• Expert credentials: Specialists like Dr. Zvi Ram hold leadership roles in European neurosurgical societies.
• Global training: Most senior neurosurgeons completed fellowships at premier United States and European institutions.
• Specialized departments: Centers feature niche units for pediatric neurosurgery, skull base, and functional disorders.

Bookimed Expert Insight: Israeli neurosurgery stands out because of the high concentration of dually certified experts. Many top surgeons, such as Dr. Zvi Lidar, are certified to practice in both Israel and the USA. This ensures that patients receive American-standard surgical care while staying in Tel Aviv or Jerusalem. Our data shows that private centers like Assuta offer significantly faster access to these specific specialists compared to the public system.

Patient Consensus: Patients note it is important to confirm a surgeon's specific volume of cases for your exact condition. They also value the ability to get expert second opinions quickly through online consultations with world-renowned professors.

Sheba Medical Center and Sourasky Medical Center (Ichilov) are among the best neurosurgery hospitals in Israel. These JCI-accredited facilities perform thousands of operations annually. They utilize advanced technologies like CyberKnife and intraoperative MRI to treat complex brain tumors and cerebrovascular lesions.

• Sheba Medical Center: Ranked among the top 10 world hospitals by Newsweek magazine.
• Sourasky (Ichilov): Reports a 98% success rate and performs 2,500+ neurosurgical operations annually.
• Hadassah Medical Center: Known for pioneering endoscopic techniques and integrated advanced research programs.
• Assuta Medical Center: Israel largest private facility specializing in minimally invasive spine procedures.
• Rambam Medical Center: Employs Nobel Prize laureates and serves as a major referral center.

Bookimed Expert Insight: Our data shows that top Israeli centers like Sourasky and Hadassah perform over 40,000 total operations yearly. This high volume allows surgeons to maintain a 90% success rate even in complex oncology cases. Patients seeking robotic spine surgery or deep brain stimulation should focus on these high-capacity municipal centers for the most experienced teams.

Patient Consensus: Patients appreciate that some hospitals quickly coordinate consultations even during regional strikes. Families of pediatric patients especially value surgeons trained at prestigious international institutions.

Israel's leading neurosurgeons include Professor Zvi Ram, Professor Shlomi Constantini, and Professor Itzhak Fried at Sourasky Medical Center. These experts specialize in awake craniotomy, pediatric brain tumors, and functional mapping. Most hold JCI accreditation and international fellowships from institutions like Johns Hopkins and Yale.

• Brain tumors: Professor Zvi Ram specializes in image-guided microsurgery and complex brain mapping techniques.
• Pediatric expertise: Professor Shlomi Constantini leads pediatric neurosurgery, focusing on endoscopic treatments and malformations.
• Functional surgery: Professor Itzhak Fried is a global authority on epilepsy and deep brain stimulation.
• Spine specialists: Dr. Zvi Lidar and Dr. Eli Ashkenazi focus on minimally invasive spinal oncology.

Bookimed Expert Insight: Data shows that top-tier Israeli neurosurgeons, such as those at Sourasky Medical Center, often hold dual board certifications in Israel and the US. This unique crossover ensures patients receive American-standard protocols. These specialists typically manage over 34,000 annual operations, providing high-volume clinical experience that smaller private clinics cannot match.

Patient Consensus: Patients note that highly qualified doctors like Professor Shlomo Constantini provide satisfactory answers quickly. People emphasize that outcomes often depend on the hospital’s integrated resources rather than just a doctor's prestige.

Israel is a global leader in neurosurgery, treating complex brain and spinal conditions using robotic-assisted and minimally invasive techniques. Highly specialized units at JCI-accredited centers like Sourasky Medical Center (Ichilov) and Hadassah Medical Center focus on neuro-oncology, pediatric neurosurgery, and functional procedures.

• Neuro-oncology: Treating glioblastoma, meningioma, and skull base tumors with 90% success rates.
• Functional neurosurgery: Performing deep brain stimulation (DBS) for Parkinson’s and drug-resistant epilepsy.
• Pediatric specialty: Specialized care for congenital defects and childhood tumors at Schneider Children’s.
• Spine surgery: Utilizing Mazor X robotic systems for scoliosis and herniated disc correction.

Bookimed Expert Insight: Israeli neurosurgical departments often function as rapid-response hubs for international patients. Data shows that large centers like Sourasky, which serves 1,800,000 patients annually, can organize expert video consultations in a very short time. This speed is critical for neuro-oncology cases where starting treatment a few days earlier significantly impacts outcomes.

Patient Consensus: Patients note that Israeli teams often accept high-risk cases that other hospitals decline. They emphasize the importance of using local coordinators to manage travel logistics or potential local disruptions during their two-week stay.

International patients traveling to Israel for neurosurgery require a valid passport, an entry permit or medical visa, and a formal hospital invitation. You must provide recent MRI or CT scans in DICOM format and detailed medical summaries. Proof of private health insurance and financial stability are also mandatory for border entry.

• Travel authorization: Most visa-exempt travelers now need an approved ETA-IL before departure.
• Hospital invitation: A signed letter from facilities like Sourasky Medical Center is required.
• Medical records: Provide updated summaries of diagnoses, medications, and previous neurological treatments.
• Imaging files: Digital copies of scans are essential for planning complex brain surgeries.
• Legal consent: Notarized power of attorney is required for patients under 18 years old.

Bookimed Expert Insight: Our data shows that top neurosurgeons at Hadassah Medical Center and Sourasky often request records 4–6 weeks before arrival. Submitting these early prevents appointment shifts. High-volume centers with over 30,000 annual operations have dedicated portals for secure DICOM file uploads. Using these ensures your surgeon reviews high-quality images before you land in Tel Aviv.

Patient Consensus: Patients emphasize bringing physical copies and digital backups of all scans on a USB drive. They also note that private insurance needs pre-authorization specifically for neurosurgery to avoid payment delays at the clinic.